SYNTHETIC CANNABIS
Synthetic cannabinoids are not derived from a plant, instead they are synthetically or “laboratory-derived” so that there is 100% consistency and predictability; just like a prescription drug. OVATION can leverage its completed research and development using plant-based cannabinoids (hemp and marijuana) in order to partner with a pharmaceutical company seeking a better delivery of their synthetic CBD or THC. Synthetic cannabis allows for approval of the finished products as a prescription pharmaceutical drug by Health Canada and the US FDA.
ANIMAL HEALTH
People across the globe are looking at cannabis as a solution to their pet health and wellness concerns. OVATION products are compatible for the animal health and will offer benefits for this growing market.